Coloplast A/S (OTCMKTS:CLPBY) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) issued its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01, Zacks reports. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.

Coloplast A/S Stock Performance

Shares of OTCMKTS CLPBY traded up $0.07 during trading hours on Tuesday, reaching $6.40. The stock had a trading volume of 11,909 shares, compared to its average volume of 584,723. The firm has a 50-day moving average of $6.76 and a 200-day moving average of $8.00. The firm has a market cap of $14.42 billion, a price-to-earnings ratio of 23.70, a PEG ratio of 2.03 and a beta of 0.15. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. Coloplast A/S has a fifty-two week low of $6.10 and a fifty-two week high of $10.03.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Coloplast A/S currently has a consensus rating of “Reduce”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.